Success Stories: Dual Petition Success with NAILG: EB-1A and NIW Approved for a PhD Candidate in Biomedical Engineering
Client’s Testimonial:
“Thank you so much for such great news! I sincerely appreciate your detailed support and preparation for both my NIW and EB1A applications.”
On April 27th, 2024 and April 16th, 2025, we received another EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approval for a PhD Candidate in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: PhD Candidate
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: April 27th, 2024 (NIW) and April 16th, 2025 (EB1A)
Processing Time: 7 months, 16 days (NIW) and 9 days (EB1A) (Premium Processing Requested)
Case Summary:
A talented researcher in biomedical engineering reached out to our law firm to pursue permanent residency through the EB-2 NIW (National Interest Waiver) route. As is standard in our process, we thoroughly reviewed his academic history, technical achievements, and scientific impact. After confirming the strength of his credentials, we submitted his NIW petition to USCIS with a strategic case presentation. Impressed by the depth and relevance of his work, our client later retained us to assist with his EB-1A (Alien of Extraordinary Ability) petition as well.
Upon reviewing the client’s profile, we found that he is a leading figure in the field of medical and electrical engineering, with highly specialized work in biomedical imaging and image processing powered by machine learning. Within these emerging areas, he has developed super-resolution microscopy systems and high-speed volumetric computed tomography innovations that have clear applications in preclinical diagnostics and future healthcare technologies.
His academic record reflects both productivity and impact, with 13 peer-reviewed journal articles, 3 peer-reviewed conference papers, 3 preprints, and 1 accepted first-authored journal article. His work has been cited 460 times by scholars from at least 43 countries, underscoring its international relevance and influence. Notably, at least 9 of his publications rank among the most highly cited in the engineering field for their respective publication years. In addition, he has completed over 100 peer reviews for respected journals, further solidifying his reputation as a trusted expert and contributor to the advancement of his discipline.
His research has earned enthusiastic praise from fellow experts in the field. One recommendation letter stated:
“[Client] is an outstanding electrical engineering researcher who has made breakthroughs in the field by developing cutting-edge computed tomography systems and has served prominent journals through his peer review activities. Ensuring that [client]’s work proceeds is therefore important not only to the research field but also to the United States and the international research community.”
Our client’s research is not only academically rigorous but deeply impactful in the real world. His work directly contributes to advancing the next generation of imaging systems and diagnostic tools, which are essential to both early disease detection and the evolution of precision medicine. The interdisciplinary nature of his expertise, spanning physics, AI, and biomedical engineering, positions him at the forefront of transformative innovation.
Furthermore, he has received funding from the National Institute of Health (NIH), the National Science Foundation (NSF), the Vodafone Americas Foundation, the Howard Hughes Medical Institute, and the Chan Zuckerberg Initiative. This support of our client’s research further serves as evidence that his project advances innovative medical technologies that improve health outcomes, providing them with new tools to drive scientific progress and contribute to breakthroughs in healthcare.
Through our carefully crafted legal strategy, we successfully demonstrated to USCIS that our client’s work is of extraordinary merit, with substantial benefit to national research priorities and the advancement of high-tech healthcare. We are proud to have helped him secure both NIW and EB-1A approvals, and we look forward to witnessing the continued impact of his groundbreaking contributions to science and technology in the U.S. and beyond.